NBY NOVABAY PHARMACEUTICALS INC Disposals and divestitures 8-K Filing 2024 - Asset Sale Announcement NovaBay Pharmaceuticals plans to sell its Avenova eyecare products and related assets to PRN Physician Recommended Nutriceuticals, and may undergo voluntary liquidation, with preliminary cash of $776,000 as of September 30, 2024.Get access to all SEC 8-K filings of the NOVABAY PHARMACEUTICALS INC